Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II integrated antibiotic treatment for high-risk chorioamnionitis in preterm labor
jRCTs071210114Phase 2Recruiting
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of azithromycin and meropenem in intraamniotic infection (IAI) and Preterm labor (PTL) (2 arms). Primary endpoint: Amounts of bacteria in amniotic fluid. Started Jan 2022; status: recruiting.
02
Drugs
azithromycinmeropenem
03
Conditions
intraamniotic infection (IAI)Preterm labor (PTL)
Beyond the preview
Go deeper on jRCTs071210114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071210114.